Navigation Links
WuXi AppTec VP and GM Invited to Join the AAMI Standards Board
Date:7/9/2008

SHANGHAI, China, July 9 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today proudly announced that Ms. Trabue D. Bryans, Vice President and General Manager of WuXi AppTec's Atlanta Operations, one of the U.S. operating subsidiaries of WuXi PharmaTech (Cayman) Inc., has been invited to join the Association for the Advancement of Medical Instrumentation (AAMI) Standards Board for a three-year term.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

Founded in 1967, the non-profit AAMI is a unique alliance of over 6,000 individuals and 375 organizations from around the world united by the common goal of increasing the understanding and beneficial use of medical instrumentation, as well as the primary resource for the industry, professions, and government for national and international standards. The AAMI standards program consists of over 100 technical committees and working groups that produce Standards, Recommended Practices, and Technical Information Reports for medical devices. Standards and Recommended Practices represent a national consensus and many have been approved by the American National Standards Institute (ANSI) as American National Standards as well as International Standardization Organization (ISO) standards.

Having served as a member of AAMI Sterilization Standards Committee, former co-chair of the AAMI Microbiological Methods Working Group, and expert member to the ISO TC 198 Micro Methods working group, Ms. Bryans will work regularly with more important responsibilities in her new role of directing and supervising all AAMI technical committee activities relating to the national standards program.

''I am very honored to be part of the national standards program, and will do my best to make a worthwhile contribution during my term. As the global medical device industry is rapidly growing and related technologies and products are converging, it is very important to have a set of standards that help regulate the research, development and commercialization of innovative medical devices,'' said Ms. Bryans.

With over 25 years of experience in medical device industry and internationally recognized for her work in microbiology and sterilization and process validation, Ms. Bryans is responsible for all operations of WuXi AppTec's Atlanta facility. She received her B.S. from University of Georgia, and M(ASCP), microbiology technologist certification by the American Society for Clinical Pathology, from Medical College of Georgia. She also completed her M.B.A. course work at Georgia State University.

''We are very proud of Trabue for her expertise and professional status,'' commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech. ''We are delighted to have such an exceptional individual whose leadership has made tremendous impact on not only national standards but also the medical device testing business of WuXi AppTec. We would like to extend our warm congratulations to Trabue and great support for her new role in AAMI.''

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. For more information, please visit: http://www.wuxipharmatech.com .


'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. WuXi PharmaTech Completes Acquisition of AppTec
2. WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.
3. AutoGenomics Invited to Present at the JPMorgan Healthcare Conference
4. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
5. Pharsight Invited to Present on Winning Strategies for R&D Productivity at New York Pharma Forum on October 15, 2007
6. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
7. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
8. Allergy Standards LTD to Attend 2008 American Academy of Allergy, Asthma and Immunology Conference
9. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards
10. Data Presented on Monogram HIV Tropism Tests at Retrovirus Conference sets New Standards of Assay Sensitivity
11. CNCA Exceeds Standards in Nutritional Supplement Quality, Protects Public
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)...  Champions Oncology, Inc. (NASDAQ: CSBR ), ... advanced technology solutions and products to personalize the development ... of new cohorts of PDX models to their existing ... Champions, product line in hepatocellular cancer, breast cancer, castrate ... non-small cell lung cancer (including EGFR mutation; ALK/ROS1 positive) ...
(Date:2/16/2017)... 2017  Rhythm, a biopharmaceutical company developing ... result in life-threatening metabolic disorders, today announced ... round of financing with existing investors including ... Enterprise Associates, Pfizer Venture Investments, Third Rock ... fund. Rhythm will use the proceeds to ...
(Date:2/15/2017)... ... 15, 2017 , ... Executive search firm, Slone Partners, announces ... Matt is a veteran life sciences and molecular diagnostics executive with extensive ... identifying inherited disease risk in future generations. In his new role, Matt will ...
(Date:2/15/2017)... Feb. 15, 2017  NASA provider SpaceX is scheduled ... the  International Space Station  no earlier than 10:01 a.m. ... will begin at 8:30 a.m. on NASA Television and ... spacecraft will lift off on the company,s Falcon ... Kennedy Space Center in ...
Breaking Biology Technology:
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
(Date:1/26/2017)... DENVER , Jan. 26, 2017  Acuity ... Trends for Biometrics and Digital Identity".  Acuity characterizes ... digital identity when increased adoption reflects a new ... "Biometrics and digital identity are ... says Maxine Most , Principal of Acuity ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds ... baby,s sock that monitors vital signs and alerts ... an infant,s oxygen saturation level drops. But pediatric ... alarm to parents, with no evidence of medical ... devices are marketed aggressively to parents of healthy ...
Breaking Biology News(10 mins):